LONDON, UK / ACCESSWIRE / December 19, 2017 / Active-Investors issued a free report on Centene Corp. (NYSE: CNC), which is readily accessible upon registration at www.active-investors.com/registration-sg/?symbol=CNC as the Company's latest news hit the wire. On December 15, 2017, the Fortune 500 Company and diversified multi-national healthcare enterprise, announced that its Washington subsidiary, Coordinated Care, has finalized the terms of an agreement with the State of Washington Office of the Commissioner (OIC) regarding its Ambetter Health Insurance Plan, and is again accepting enrollment in the state of Washington. Sign up now for our free research reports at:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Centene most recent news is on our radar and we have decided to include it on our blog post. Today's free coverage is available at:

www.active-investors.com/registration-sg/?symbol=CNC

Terms and Conditions of the Agreement

Coordinated Care, is a wholly-owned subsidiary of Centene. It is a managed care organization that provides healthcare services to more than 200,000 members across the Washington State through affordable and reliable health care plans.

Coordinated Care has been allowed to resume enrollment in new Obamacare plans, three days after being ordered to terminate sales over complaints that there were not enough doctors in the insurer's provider network. It was fined $1.5 million as it failed to resolve the complaints about the size of its networks of doctors, specialists, and hospitals covered by the insurer's plans. However, $1 million of the fine will be suspended if there are no further violations over the next two years.

Coordinated Care to Make Refinements to its Network Reporting Processes

Coordinated Care will continue to work in collaboration with the OIC, by offering affordable healthcare coverage to the State of Washington's consumers through the Ambetter marketplace program. The Company is continuing to make refinements and improvements to its network reporting processes and is also addressing known issues in its network in select regions of the state. Ambetter serves rural counties, which may not have all specialists located within them. However, the Company's members can access these specialists located elsewhere within its network footprint. Coordinated Care is known to have over 15,000 providers in-network, statewide, representing all specialties, including 40 hospitals.

Coordinated Care Previously Selected For Fully Integrated Managed Care Contract

On May 25, 2017, Coordinated Care was selected by the Washington State Health Care Authority to provide managed care services to Apple Health's Fully Integrated Managed Care (FIMC) beneficiaries in three counties that make up the North Central Region. The contract is expected to commence January 01, 2018, with an additional county being added no later than 2020. Under the new contract, the Company expects to grow and build on its current membership of over 13,400 in the region.

Centene Reported Q3 2017 Results in October

On October 24, 2017, the Company announced its financial results for the third quarter ended September 30, 2017, reporting diluted earnings per share (EPS) of $1.16 compared to $0.84 for the same quarter of 2016, and adjusted diluted EPS of $1.35 compared to $1.12 for Q3 2016. Centene reported total revenues of $11.9 billion for Q3 2017, representing a 10% growth compared to Q3 2016, and operating cash flow of $97 million for Q3 2017 and $1,039 million for the nine months ended September 30, 2017.

About Centene Corp.

Founded in 1984, Centene is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates local health plans and offers a range of health insurance solutions. Centene is headquartered in St. Louis, Missouri.

Stock Performance Snapshot

December 18, 2017 - At Monday's closing bell, Centene's stock climbed 3.24%, ending the trading session at $97.93.

Volume traded for the day: 3.22 million shares, which was above the 3-month average volume of 1.81 million shares.

Stock performance in the last month ? up 2.07%; previous three-month period ? up 9.08%; past twelve-month period ? up 73.27%; and year-to-date - up 73.30%

After yesterday's close, Centene's market cap was at $17.64 billion.

Price to Earnings (P/E) ratio was at 20.25.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors